Main Article Content

A phase I trial of hypoxoside as an oral prodrug for cancer therapy - absence oftoxicity


B.J. Smit
C.F. Albrecht
R.W. Liebenberg
P.B. Kruger
M. Freestone
L. Gouws
E. Theron
P.J.D. Bouic
S. Etsebeth
P.P. van Jaarsveld

Abstract

No Abstract.

Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574